Literature DB >> 31517529

Recent advances of thiazole hybrids in biological applications.

Mehmet Gümüş1,2, Mehmet Yakan1, İrfan Koca1.   

Abstract

Thiazoles have attracted much synthetic interest due to their wide variety of biological properties and are important members of heterocyclic compounds. In recent years, studies on the synthesis of thiazole compounds have been increasing because of the properties of this core. In particular, the hybrid structures in which the thiazole ring and the other nuclei are linked have gained popularity. Hybrid structures are formed by the combination of different groups of chemical reactivity and biological activity characteristics. In this review, we highlight recent developments related to hybrid structures containing a thiazole core, recently developed as anticancer, antibacterial, anti-inflammatory, analgesic, anti-tubercular, antialzheimer and antidiabetic compounds.

Entities:  

Keywords:  anticancer; biological activity; hybride compounds; thiazole

Mesh:

Substances:

Year:  2019        PMID: 31517529     DOI: 10.4155/fmc-2018-0196

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  10 in total

1.  Domino/Cascade and Multicomponent Reactions for the Synthesis of Thiazole Derivatives.

Authors:  Mohammad A Alam
Journal:  Curr Org Chem       Date:  2022-03-24       Impact factor: 2.226

Review 2.  Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents.

Authors:  Mohammed F Arshad; Aftab Alam; Abdullah Ayed Alshammari; Mohammed Bader Alhazza; Ibrahim Mohammed Alzimam; Md Anish Alam; Gulam Mustafa; Md Salahuddin Ansari; Abdulelah M Alotaibi; Abdullah A Alotaibi; Suresh Kumar; Syed Mohammed Basheeruddin Asdaq; Mohd Imran; Pran Kishore Deb; Katharigatta N Venugopala; Shahamah Jomah
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

3.  Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.

Authors:  Tarfah Al-Warhi; Ahmed M El Kerdawy; Mohamed A Said; Amgad Albohy; Zainab M Elsayed; Nada Aljaeed; Eslam B Elkaeed; Wagdy M Eldehna; Hatem A Abdel-Aziz; Miral A Abdelmoaz
Journal:  Drug Des Devel Ther       Date:  2022-05-16       Impact factor: 4.319

Review 4.  An Overview of the Synthesis and Antimicrobial, Antiprotozoal, and Antitumor Activity of Thiazole and Bisthiazole Derivatives.

Authors:  Anca-Maria Borcea; Ioana Ionuț; Ovidiu Crișan; Ovidiu Oniga
Journal:  Molecules       Date:  2021-01-25       Impact factor: 4.411

5.  Traceless solid-phase synthesis and β-turn propensity of 1,3-thiazole-based peptidomimetics.

Authors:  Aizhan Abdildinova; Young-Dae Gong
Journal:  RSC Adv       Date:  2021-01-04       Impact factor: 3.361

6.  A one-pot electrochemical synthesis of 2-aminothiazoles from active methylene ketones and thioureas mediated by NH4I.

Authors:  Shang-Feng Yang; Pei Li; Zi-Lin Fang; Sen Liang; Hong-Yu Tian; Bao-Guo Sun; Kun Xu; Cheng-Chu Zeng
Journal:  Beilstein J Org Chem       Date:  2022-09-15       Impact factor: 2.544

7.  Synthesis and Molecular Docking Study of New Thiazole Derivatives as Potential Tubulin Polymerization Inhibitors.

Authors:  Azhar O El-Abd; Said M Bayomi; Ashraf K El-Damasy; Basem Mansour; Naglaa I Abdel-Aziz; Magda A El-Sherbeny
Journal:  ACS Omega       Date:  2022-09-07

Review 8.  Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.

Authors:  Dimitris Matiadis; Marina Sagnou
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

9.  Synthesis and Biological Evaluation of Thiazole-Based Derivatives as Potential Acetylcholinesterase Inhibitors.

Authors:  Aya Y Hemaida; Ghada S Hassan; Azza R Maarouf; Jacques Joubert; Ali A El-Emam
Journal:  ACS Omega       Date:  2021-07-19

10.  Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors.

Authors:  Guangcheng Wang; Wenjing Liu; Meiyan Fan; Min He; Yongjun Li; Zhiyun Peng
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.